| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963077 | Vaccine | 2016 | 7 Pages |
Abstract
Thus, we found no evidence of an increased risk of VTE associated with HPV4 among 9â26-year-old females. A particular strength of this evaluation was its control for both time-invariant and contraceptive-related time-varying potential confounding.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
W. Katherine Yih, Sharon K. Greene, Lauren Zichittella, Martin Kulldorff, Meghan A. Baker, Jill L.O. de Jong, Ruth Gil-Prieto, Marie R. Griffin, Robert Jin, Nancy D. Lin, Cheryl N. McMahill-Walraven, Megan Reidy, Nandini Selvam, Mano S. Selvan,